IP Library Assignment 024380/0192
Patent Assignment
Reel/Frame 024380/0192

Change of Name

Recorded: 2010-05-13 Pages: 18
Assignor
HANALL PHARMACEUTICAL CO., LTD.
Executed: 2010-03-29
Assignee
HANALL BIOPHARMA CO., LTD.
400-1, SANGSEO-DONG, DAEDEOK-GU,, DAEJEON 306-120, SEOUL, KOREA, REPUBLIC OF
Covered Property (1)
Protease Resistant Modified Interferon Alpha Polypeptides
Patent: 7,611,700 →
Application: 10/658,834 →
Publication: US 2004/0132977
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 3, 2004
From: GANTIER, RENE; VEGA, MANUEL; DRITTANTI, LILA; GUYON, THIERRY
To: NAUTILUS BIOTECH, S.A.
Reel/Frame 014957/0642 →
License Agreement Sep 11, 2008
From: NAUTILUS BIOTECH, S.A.
To: CREABILIS THERAPEUTICS SPA
Reel/Frame 021521/0699 →
Assignment of Assignor's Interest Jul 24, 2009
From: NAUTILUS BIOTECH, S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023006/0088 →
Corrective Assignment to Correct the Assignee's Country Previously Recorded on Reel 023006 Frame 0088. Assignor(S) Hereby Confirms the Assignee's Country Is: the Republic of Korea (South Korea). Sep 28, 2009
From: NAUTILUS BIOTECH S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023294/0328 →